

Central pontine myelinolysis is nerve damage caused by the destruction of the layer (myelin sheath) covering nerve cells in the brainstem (pons).
The destruction of the myelin sheath that coats nerve cells prevents signals from being properly conducted within the nerve. This decreases its ability to communicate with other cells. The most common cause of central pontine myelinolysis is a rapid, drastic change in sodium levels in the body. Most commonly, this occurs when someone is being treated for low levels of sodium (hyponatremia) and the levels rise too fast. It also can occasionally occur when high levels of sodium in the body (hypernatremia) are corrected too quickly.
This condition does not occur on its own. It is a complication of treatment for other conditions or the other conditions themselves.
People at risk include those with low sodium levels from any cause, alcoholism, Wernicke-Korsakoff syndrome, general ill health, and malnutrition associated with serious illnesses.
An examination may indicate involvement of all four arms and legs (spastic quadriplegia) or weakness of the face, arms, and legs (upper motor neuron syndromes). Reflexes may be abnormal. An eye examination may show loss of control of eye muscles, particularly cranial nerve VI paralysis (see cranial mononeuropathy VI).
A head MRI scan would reveal an abnormality in the brainstem (pons). This is the main diagnostic test.
Other tests may include:
This is an emergency disorder that requires hospitalization for diagnosis and treatment. There is no known cure for central pontine myelinolysis and treatment is focused on relieving symptoms.
Double vision may be reduced with the use of an eye patch.
Physical therapy may help maintain muscle strength, mobility and function in weakened arms and legs.
The nerve damage caused by central pontine myelinolysis is usually long-lasting. The disorder can cause serious chronic (long-term) disability.
Go to the emergency room or call 911 if seizures, muscle weakness, or other symptoms of this condition occur.
Gradual, controlled treatment of low or high sodium levels may reduce the risk of nerve damage in the pons. Being aware of how some medications can change sodium levels can prevent these levels from changing too quickly.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. � 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.